REMINDER: Our user survey closes on Friday, please submit your responses here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRB..L Regulatory News (RB.)

  • There is currently no data for RB.

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Holding(s) in Company

13 Jan 2016 14:32

RNS Number : 7789L
Reckitt Benckiser Group PLC
13 January 2016
 

 

TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARESi

1. Identity of the issuer or the underlying issuerof existing shares to which voting rights areattached: ii

Reckitt Benckiser Group plc

2 Reason for the notification (please tick the appropriate box or boxes):

An acquisition or disposal of voting rights

X

An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached

An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments

An event changing the breakdown of voting rights

Other (please specify):

3. Full name of person(s) subject to thenotification obligation: iii

JAB Holdings B.V.

4. Full name of shareholder(s)  (if different from 3.):iv

N/A

5. Date of the transaction and date onwhich the threshold is crossed orreached: v

Date of the transaction: 12 January 2016

Date on which the threshold is crossed: 12 January 2016

6. Date on which issuer notified:

13 January 2016

7. Threshold(s) that is/are crossed orreached: vi, vii

below 10%

 

8. Notified details:

A: Voting rights attached to shares viii, ix

Class/type ofshares

if possible usingthe ISIN CODE

Situation previousto the triggeringtransaction

Resulting situation after the triggering transaction

NumberofShares

NumberofVotingRights

Numberof shares

Number of votingrights

% of voting rights x

Direct

Direct xi

Indirect xii

Direct

Indirect

GB00B24CGK77

71,055,565

71,055,565

69,973,794

69,973,794

N/A

9.89 %

N/A

B: Qualifying Financial Instruments

Resulting situation after the triggering transaction

Type of financialinstrument

Expirationdate xiii

Exercise/Conversion Period xiv

Number of votingrights that may beacquired if theinstrument isexercised/ converted.

% of votingrights

N/A

N/A

N/A

N/A

N/A

C: Financial Instruments with similar economic effect to Qualifying Financial Instruments xv, xvi

Resulting situation after the triggering transaction

Type of financialinstrument

Exercise price

Expiration date xvii

Exercise/Conversion period xviii

Number of voting rights instrument refers to

 

% of voting rights xix, xx

 

N/A

N/A

N/A

N/A

N/A

Nominal

Delta

N/A

N/A

Total (A+B+C)

Number of voting rights

Percentage of voting rights

69,973,794

9.89 %

 

9. Chain of controlled undertakings through which the voting rights and/or thefinancial instruments are effectively held, if applicable: xxi

 

N/A

Proxy Voting:

10. Name of the proxy holder:

N/A

11. Number of voting rights proxy holder will ceaseto hold:

N/A

12. Date on which proxy holder will cease to holdvoting rights:

N/A

13. Additional information:

N/A

14. Contact name:

Christine Logan, Company Secretary

15. Contact telephone number:

01753 217800

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
HOLUOOSRNRAAAAR
Date   Source Headline
9th Apr 202010:00 amRNSDirectorate Change
6th Apr 202011:42 amRNSAnnual Financial Report
3rd Apr 202010:31 amRNSDirector Declaration
1st Apr 202011:26 amRNSTotal Voting Rights
24th Mar 20204:57 pmRNSDirector/PDMR Shareholding
24th Mar 20204:41 pmRNSSecond Price Monitoring Extn
24th Mar 20204:35 pmRNSPrice Monitoring Extension
12th Mar 20205:08 pmRNSDirector/PDMR Shareholding
9th Mar 20204:45 pmRNSDirector/PDMR Shareholding
3rd Mar 20204:26 pmRNSDirector/PDMR Shareholding
2nd Mar 20201:11 pmRNSTotal Voting Rights
27th Feb 20207:00 amRNSFull Year Results 2019
3rd Feb 202011:16 amRNSTotal Voting Rights
2nd Jan 202012:20 pmRNSTotal Voting Rights
4th Dec 20191:30 pmRNSDirectorate Change
2nd Dec 201912:00 pmRNSTotal Voting Rights
1st Nov 201912:00 pmRNSTotal Voting Rights
29th Oct 20194:30 pmRNSDirector/PDMR Shareholding
28th Oct 201911:21 amRNSDirector/PDMR Shareholding
24th Oct 20192:30 pmRNSDirector/PDMR Shareholding
22nd Oct 20197:00 amRNSQ3 2019 Trading Update
21st Oct 201910:15 amRNSDirectorate Change
1st Oct 201911:51 amRNSTotal Voting Rights
30th Sep 20193:12 pmRNSDirector/PDMR Shareholding
18th Sep 201912:00 pmRNSDirectorate Change
3rd Sep 20191:00 pmRNSDirector/PDMR Shareholding
2nd Sep 20191:00 pmRNSDirectorate Change
2nd Sep 201912:37 pmRNSTotal Voting Rights
30th Aug 20193:00 pmRNSDirector/PDMR Shareholding
6th Aug 20192:07 pmRNSDirector/PDMR Shareholding
1st Aug 20199:48 amRNSTotal Voting Rights
30th Jul 20197:00 amRNSHalf Year Results 2019
29th Jul 20199:30 amRNSDirectorate Change
11th Jul 20197:00 amRNSAgreement to resolve all federal investigations
1st Jul 201911:31 amRNSTotal Voting Rights
12th Jun 20197:00 amRNSRB CEO Announcement
3rd Jun 201910:49 amRNSTotal Voting Rights
28th May 201910:40 amRNSDirector/PDMR Shareholding
23rd May 20194:40 pmRNSDirector/PDMR Shareholding
22nd May 201911:45 amRNSDirector/PDMR Shareholding
13th May 20193:01 pmRNSDirector/PDMR Shareholding
9th May 20193:28 pmRNSResult of AGM
2nd May 20197:00 amRNSQ1 Trading Update
1st May 201910:46 amRNSDirectorate Change
1st May 20199:00 amRNSTotal Voting Rights
10th Apr 201910:37 amRNSUS Justice Department indictment of Indivior Plc
4th Apr 201912:45 pmRNSDirector Declaration
2nd Apr 20194:56 pmRNSAnnual Financial Report
1st Apr 20199:30 amRNSTotal Voting Rights
27th Mar 20192:58 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.